SCHEMBL5491797

SCHEMBL5491797

CON(C(=O)c1ccccc1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
KCNK3 O14649 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46
LMNA P02545 1/20 0.46
OPRM1 P35372 1/20 0.45
OPRL1 P41146 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SRD5A2 P31213 1/20 0.44
MAOB P27338 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
HTT P42858 1/20 0.43
GAA P10253 1/20 0.42
CNR2 P34972 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12544171 0.81 NR1H3 (0.57) CES2RXFP1LMNAOPRM1OPRL1
SCHEMBL4461612 0.81 ATM (0.45) RXFP1KCNK3NPSR1MEN1KMT2A
SCHEMBL4526462 0.80 HPGD (0.50) CES2NPSR1KMT2AALDH1A1HTT
SCHEMBL28020267 0.78 CES2 (0.51) CES2KCNK3LMNAOPRM1OPRL1
SCHEMBL18825315 0.77 HTT (0.40) CES2KCNK3LMNAOPRM1OPRL1
SCHEMBL17891690 0.76 RXFP1 (0.43) RXFP1LMNAMEN1KMT2AALDH1A1
SCHEMBL20401477 0.75 HSD17B1 (0.48) RXFP1HSD17B1HSD17B2HTTMAPT
SCHEMBL11536412 0.74 TP53 (0.42) RXFP1KCNK3NPSR1LMNAMEN1
SCHEMBL323339 0.74 CES2 (0.57) CES2NPSR1LMNAOPRM1OPRL1
SCHEMBL17671165 0.72 CES2 (0.44) CES2RXFP1NPSR1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC. (US) 2007-09-26 EP claimed
WO-2006039718-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2006-04-13 WO claimed